Why the study?
The correlation between PFAS exposure and hypertension remains inconsistent with methodological limitations and predominance of cross-sectional studies.
Does exposure to perfluoroalkyl and polyfluoroalkyl substances (PFAS) increase the risk of hypertension in human populations?
Does exposure to perfluoroalkyl and polyfluoroalkyl substances (PFAS) increase the risk of hypertension in human populations?
Current evidence suggests a positive association between PFAS exposure and hypertension driven by multiple biological pathways, though prospective studies are needed to establish causation.
The correlation between perfluoroalkyl and polyfluoroalkyl substances (PFAS) and hypertension remains inconsistent.We narrative reviewed the correlation between PFAS and hypertension in terms of the current status of PFAS contamination, existing studies, and potential mechanisms.The majority of studies reported a positive association between PFAS exposure and hypertension, though results vary considerably across studies.Potential mechanistic pathways include altered expression of nuclear receptors, oxidative stress, impaired renal sodium handling, and disturbances in thyroid hormone levels.Inconsistencies in the literature appear to stem from differences in PFAS compounds assessed, study designs, population characteristics, and outcome definitions.Given the predominance of cross-sectional studies and other methodological limitations, these findings should be interpreted as association rather than causation, highlighting the need for prospective studies to clarify the relationship.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) conducted a review in Hypertension. Perfluoroalkyl and polyfluoroalkyl substances (PFAS) was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: